alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Swift Energy
Pension Partners 1995-B, Ltd.'s balance sheet and statement of operations
contained in its Form 10-K for the year ended December 31, 1999 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                         704,809
<SECURITIES>                                    0
<RECEIVABLES>                                  312,349
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               1,017,158
<PP&E>                                         2,301,939
<DEPRECIATION>                                 (733,548)
<TOTAL-ASSETS>                                 2,585,549
<CURRENT-LIABILITIES>                          14,716
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     2,570,833
<TOTAL-LIABILITY-AND-EQUITY>                   2,585,549
<SALES>                                        472,984
<TOTAL-REVENUES>                               504,975
<CGS>                                          0
<TOTAL-COSTS>                                  236,990<F1>
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                185,836
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            185,836
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   185,836
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0

<FN>
<F1>Includes lease operating expenses, production taxes and depreciation and
amortization expense.  Excludes general and administrative and interest expense.
</FN>


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

# AGENCY:

Small Business Administration.

# ACTION:

Notice of open Federal advisory committee meeting.

# SUMMARY:

The SBA is issuing this notice to announce the date, time and agenda for a meeting of the National Small Business Development Center Advisory Board. The meeting will be open to the public; however, advance notice of attendance is required.

# DATES:

Wednesday, February 14, 2024, at 1:00 PM EST.

# ADDRESSES:

Meeting will be held in-person and via Microsoft Teams.

# FOR FURTHER INFORMATION CONTACT:

                        Rachel Karton, Office of Small Business Development Centers, U.S. Small Business Administration, 409 Third Street SW, Washington, DC 20416;                         *Rachel.newman-karton@sba.gov;*                         202-619-1816.                    

If anyone wishes to be a listening participant or would like to request accommodations, please contact Rachel Karton at the information above.

# SUPPLEMENTARY INFORMATION:

Pursuant to section l0(a) of the Federal Advisory Committee Act (5 U.S.C. appendix 2), the SBA announces the meetings of the National SBDC Advisory Board. This Board provides advice and counsel to the SBA Administrator and Associate Administrator for Small Business Development Centers.

## Purpose

The purpose of the meeting is to discuss the following pertaining to the SBDC Program:
    - Annual Plan/White Paper
    - Outreach and Engagement with the SBDC State Directors

Andrienne Johnson,

Committee Management Officer.

[FR Doc. 2024-00914 Filed 1-17-24; 8:45 am]

BILLING CODE 8026-09-P
II

104TH CONGRESS

2D SESSION S. 1596

To direct a property conveyance in the State of California.

IN THE SENATE OF THE UNITED STATES

MARCH 7 (legislative day, MARCH 6), 1996

Mr. MURKOWSKI (for himself and Mr. JOHNSTON) introduced the following

bill; which was read twice and referred to the Committee on Energy and

Natural Resources

A BILL

To direct a property conveyance in the State of California.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Ward Valley Land

5 Transfer Act’’.

6 SEC. 2. CONVEYANCE OF PROPERTY.

7 Effective upon the tendering to the Secretary of the

8 Treasury of $500,100 on behalf of the State of California

9 and the tendering to the Chairman of the Nuclear Regu10 latory Commission of a written commitment by the State

11 to carry out environmental monitoring and protection
2

S 1596 IS

1 measures based on recommendations of the National

2 Academy of Sciences subject to Federal oversight by the

3 Nuclear Regulatory Commission pursuant to 42 U.S.C.

4 2021, as amended, all right, title and interest of the

5 United States in the property depicted on a map des6 ignated USGS 7.5 minute quadrangle, west of Flattop

7 Mountain, CA 1984, entitled ‘‘Location Map for Ward

8 Valley Site’’, located in San Bernardino Meridian, Town9 ship 9 North, Range 19 East, and improvements thereon,

10 together with all necessary easements for utilities and in11 gress and egress to such property, including, but not lim12 ited to, the right to improve those easements, are conveyed

13 by operation of law to the Department of Health Services

14 of the State of California. Upon the request of the State

15 of California, the Secretary of the Interior shall provide

16 evidence of title transfer.

Æ
#### Jeffrey R. BILBO, Plaintiff—Appellant, v. DYNCORP, a Delaware Corporation, Defendant—Appellee.

No. 01-57039.

D.C. No. CV-00-00917-DOC.

United States Court of Appeals, Ninth Circuit.

Argued and Submitted Dec. 6, 2002.

Decided Jan. 8, 2003.

*417Before BROWNING, KOZINSKI and WARDLAW, Circuit Judges.

MEMORANDUM *

The district court did not err in granting summary judgment to DynCorp on Bilbo’s breach of contract claim. Bilbo’s employment agreement allowed DynCorp to discharge him for cause, including “[fjailure ... to satisfactorily perform his duties under this agreement in a manner acceptable in the trade as those duties are specified by DynCorp and the United States Government.” DynCorp argues that this provision allowed it to terminate Bilbo if he was unable to perform his duties under the contract, and Bilbo does not dispute this interpretation.

Uncontradicted evidence showed that the Army considered Bilbo an “embarrassment to the U.S. Army and to NATO forces” and that it had “command directed” DynCorp to “remove [Bilbo] from Bosnia within 72 hours.” By ordering Bilbo out of the country, the Army necessarily implied that it would no longer permit him to work at the Army base there. No reasonable jury could find otherwise. Bilbo was unable to perform under the contract, and the Employee Agreement therefore gave DynCorp the right to discharge him.

DynCorp was not required to investigate, give notice or afford a chance to respond in order to determine whether cause existed. *Cf. Cotran v. Rollins Hu-dig Hall Int’l, Inc.,*17 Cal.4th 93, 108-09, 69 Cal.Rptr.2d 900, 948 P.2d 412 (1998). The contractual limitations on DynCorp’s right to discharge were explicit rather than implied, so the necessary procedures are determined by the agreement’s language. *Id.*at 96 n. 1, 69 Cal.Rptr.2d 900, 948 P.2d 412. The agreement does not afford Bilbo any of the procedural safeguards that he demands.

In any case, there is no genuine dispute that cause existed. Bilbo’s inability to perform was sufficient cause whether or not the Army’s accusations were true. Further investigation may have revealed that the Army’s accusations were inaccurate, but it would not have changed the fact that the Army had ordered him out of the *418country. Even if Bilbo later persuaded the Army to change its mind, cause would still have existed when he was terminated, because Bilbo was unable to perform his duties under the employment agreement at that time.

AFFIRMED.

*

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-29-1996
<PERIOD-START>                             OCT-02-1995
<PERIOD-END>                               SEP-29-1996
<EXCHANGE-RATE>                                      1
<CASH>                                          10,959
<SECURITIES>                                     1,016
<RECEIVABLES>                                   42,337
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                56,653
<PP&E>                                           5,527
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  63,906
<CURRENT-LIABILITIES>                           21,312
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            89
<OTHER-SE>                                      36,187
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                               285,519
<CGS>                                                0
<TOTAL-COSTS>                                  215,990
<OTHER-EXPENSES>                                58,304
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  64
<INCOME-PRETAX>                                 12,007
<INCOME-TAX>                                     7,794
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,213
<EPS-PRIMARY>                                      .89
<EPS-DILUTED>                                        0
        

</TABLE>
EXHIBIT
31.3
 **CERTIFICATIONS**
 
 I, Larry
Hannappel, certify that:
 
 1. I have
reviewed this annual report on Form 10-K of Century Casinos,
Inc.;
 
 2. Based
on my knowledge, this annual report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this annual
report;
 
 3. Based
on my knowledge, the financial statements, and other financial information
included in this annual report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this annual report;
 
 4. The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
 a)
designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;
 
 b)
evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this annual report based on such evaluation; and
 
 c)
disclosed in this annual report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and
 
 5. The
registrant's other certifying officers and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):
 
 a) all
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant's ability to record, process, summarize and
report financial information; and
 
 b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal control over financial
reporting.
 
 Date: May
27, 2005
 
 
 /s/ Larry
Hannappel
 ________________________________
 Larry
Hannappel
 Senior
Vice President, Secretary and Treasurer
#### Arnold STAFFORD, Petitioner-Appellant, v. Ronald J. ANGELONE, Respondent-Appellee.

No. 02-7862.

United States Court of Appeals, Fourth Circuit.

Submitted Feb. 6, 2003.

Decided Feb. 13, 2003.

Arnold Stafford, Appellant Pro Se. Richard Carson Vorhis, Robert H. Anderson, III, Office of the Attorney General of Virginia, Richmond, Virginia, for Appellee.

Before WILKINS, MICHAEL, and SHEDD, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

PER CURIAM.

Arnold Stafford seeks to appeal the district court’s order denying relief on his petition filed under 28 U.S.C. § 2254 (2000). An appeal may not be taken to this court from the final order in a habeas corpus proceeding in which the detention complained of arises out of process issued by a state court unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of appealability will not issue for claims addressed by a district court on the merits absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). As to claims dismissed by a district court solely on procedural grounds, a certificate of appealability will not issue unless the petitioner can demonstrate both “(1) ‘that jurists of reason would find it debatable whether the petition states a valid claim of the denial of a constitutional right’ and (2) ‘that jurists of reason would find it debatable whether the district court was correct in its procedural ruling.’ ” *Rose v. Lee,*252 F.3d 676, 684 (4th Cir.) (quoting *Slack v. McDaniel,*529 U.S. 473, 484, 120 S.Ct. 1595, 146 L.Ed.2d 542 (2000)), *cert. denied,*534 U.S. 941, 122 S.Ct. 318, 151 L.Ed.2d 237 (2001). We have reviewed the record and conclude for the reasons stated by the district court that Stafford has not satisfied either standard. *See Stafford v. Angelone,*CA-02-756-7 (W.D.Va. Oct. 18, 2002). Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
Exhibit 32.1
 CERTIFICATION PURSUANT TO
RULE 13a-14(b) OR RULE 15d-14(b) OF THE
SECURITIES EXCHANGE ACT OF 1934
AND 18 U.S.C. SECTION 1350
  Date: March 17, 2009
    /s/ Robert J. PhillippyRobert J. PhillippyPresident and Chief Executive Officer
(Principal Executive Officer)
```

[Federal Register Volume 77, Number 49 (Tuesday, March 13, 2012)]
[Notices]
[Page 14729]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5948]

[[Page 14729]]

=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS

Agenda and Notice of Public Meeting of the Ohio Advisory 
Committee

    Notice is hereby given, pursuant to the provisions of the rules and 
regulations of the U.S. Commission on Civil Rights (Commission), and 
the Federal Advisory Committee Act (FACA), that a fact finding meeting 
of the Ohio Advisory Committee to the Commission will convene at 9 a.m. 
and adjourn at 5 p.m. on April 4, 2012, at Wilmington College, McCoy 
Room, College Street, Wilmington, OH 45177. The purpose of the meeting 
is to conduct a fact finding on civil rights issues regarding barriers 
to entrepreneurship in Ohio. Participants of the meeting will include 
community representatives, government officials, business leaders, and 
other interested parties.
    Members of the public are entitled to submit written comments; the 
comments must be received in the regional office by May 4, 2012. The 
address is 55 W. Monroe St., Suite 410, Chicago, IL 60603. Persons 
wishing to email their comments, or to present their comments verbally 
at the meeting, or who desire additional information should contact 
Carolyn Allen, Administrative Assistant, (312) 353-8311, or by email: 
callen@usccr.gov.
    Hearing-impaired persons who will attend the meeting and require 
the services of a sign language interpreter should contact the Regional 
Office at least ten (10) working days before the scheduled date of the 
meeting.
    Records generated from this meeting may be inspected and reproduced 
at the Midwestern Regional Office, as they become available, both 
before and after the meeting. Persons interested in the work of this 
advisory committee are advised to go to the Commission's Web site, 
www.usccr.gov, or to contact the Midwestern Regional Office at the 
above email or street address.
    The meeting will be conducted pursuant to the provisions of the 
rules and regulations of the Commission and FACA.

    Dated in Washington, DC, March 7, 2012.
Peter Minarik,
Acting Chief, Regional Programs Coordination Unit.
[FR Doc. 2012-5948 Filed 3-12-12; 8:45 am]
BILLING CODE 6335-01-P
```
[Federal Register Volume 89, Number 15 (Tuesday, January 23, 2024)]
[Notices]
[Page 4309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01160]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-1262]


Notice of Approval of Product Under Voucher: Rare Pediatric 
Disease Priority Review Voucher

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
issuance of approval of a product redeeming a priority review voucher. 
The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to 
award priority review vouchers to sponsors of approved rare pediatric 
disease product applications that meet certain criteria. FDA is 
required to publish notice of the issuance of priority review vouchers 
as well as the approval of products redeeming a priority review 
voucher. FDA has determined that the supplemental application 
(Supplement-1) for ZEPOSIA (ozanimod), approved May 27, 2021, meets the 
criteria for redeeming a priority review voucher.

FOR FURTHER INFORMATION CONTACT: Cathryn Lee, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-1394, email: 
<a href="/cdn-cgi/l/email-protection#f2b193869a808b9cdcbe9797b2949693dc9a9a81dc959d84"><span class="__cf_email__" data-cfemail="b1f2d0c5d9c3c8df9ffdd4d4f1d7d5d09fd9d9c29fd6dec7">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: FDA is announcing the approval of a product 
redeeming a rare pediatric disease priority review voucher. Under 
section 529 of the FD&C Act (21 U.S.C. 360ff), FDA will report the 
issuance of rare pediatric disease priority review vouchers and the 
approval of products for which a voucher was redeemed. FDA has 
determined that the supplemental application (Supplement-1) for ZEPOSIA 
(ozanimod) meets the redemption criteria.
    For further information about the Rare Pediatric Disease Priority 
Review Voucher Program and for a link to the full text of section 529 
of the FD&C Act, go to https://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/RarePediatricDiseasePriorityVoucherProgram/default.htm. For further 
information about ZEPOSIA (ozanimod), go to the ``Drugs@FDA'' website 
at https://www.accessdata.fda.gov/scripts/cder/daf/.

    Dated: January 17, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-01160 Filed 1-22-24; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>